This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kanazawa, I. Articles by Sugimoto, T. Search for Related Content PubMed PubMed Citation Articles by Kanazawa, I. Articles by Sugimoto, T. Related Collections Cardiovascular Endocrinology Diabetes and Insulin Metabolism

Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

Department of Internal Medicine 1, Shimane University School of Medicine, Shimane 693-8501, Japan

Address all correspondence and requests for reprints to: Toru Yamaguchi, M.D., Ph.D., Department of Internal Medicine 1, Shimane University School of Medicine, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan. E-mail: yamaguch{at}med.shimane-u.ac.jp.

Context: Recent animal studies showed that osteocalcin action is related to not only bone metabolism but also glucose metabolism and fat mass. We investigated the relationship between two bone formation markers, serum osteocalcin and bone-specific alkaline phosphatase, and glucose metabolism, serum adiponectin, and the amount of fat mass as well as atherosclerosis parameters in men and postmenopausal women with type 2 diabetes.

Methods: A total of 179 men and 149 postmenopausal women were recruited consecutively, and radiographic and biochemical characteristics were collected. Brachial-ankle pulse wave velocity (baPWV) and intima-media thickness (IMT) were evaluated as the parameters of atherosclerosis.

Results: Multiple regression analysis adjusted for age, duration of diabetes, body mass index, and serum creatinine showed that osteocalcin negatively correlated with fasting plasma glucose and hemoglobin A_1c in both men and postmenopausal women (P < 0.05) and with percent fat, baPWV, and IMT in men (P < 0.05). Osteocalcin positively correlated with total adiponectin in postmenopausal women (P < 0.001). After additional adjustments for systolic blood pressure, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, hemoglobin A_1c, and Brinkmann index, osteocalcin still significantly and negatively correlated with baPWV and IMT in men. In contrast, osteocalcin did not correlate with fasting C-peptide, and bone-specific alkaline phosphatase did not correlate with any variable in either men or postmenopausal women.

Conclusions: Serum osteocalcin is associated with glucose and total adiponectin levels, fat mass, and atherosclerosis parameters in patients with type 2 diabetes, suggesting that osteocalcin is important for not only bone metabolism but also glucose and fat metabolism.

This article has been cited by other articles:

				M. Zhou, X. Ma, H. Li, X. Pan, J. Tang, Y. Gao, X. Hou, H. Lu, Y. Bao, and W. Jia Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals Eur. J. Endocrinol., November 1, 2009; 161(5): 723 - 729. [Abstract] [Full Text] [PDF]

				J. Bacchetta, S. Boutroy, F. Guebre-Egziabher, L. Juillard, J. Drai, S. Pelletier, M. Richard, A. Charrie, M. C. Carlier, R. Chapurlat, et al. The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3120 - 3125. [Abstract] [Full Text] [PDF]

				N. Sucunza, M. J. Barahona, E. Resmini, J.-M. Fernandez-Real, W. Ricart, J. Farrerons, J. Rodriguez Espinosa, A.-M. Marin, T. Puig, and S. M. Webb A Link between Bone Mineral Density and Serum Adiponectin and Visfatin Levels in Acromegaly J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3889 - 3896. [Abstract] [Full Text] [PDF]

				I. Kanazawa, T. Yamaguchi, M. Yamauchi, M. Yamamoto, S. Kurioka, S. Yano, and T. Sugimoto Adiponectin Is Associated with Changes in Bone Markers during Glycemic Control in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3031 - 3037. [Abstract] [Full Text] [PDF]